S&P 500 survivors
Top 20 survivors, 1957 to 2003
|
| Rank |
2003 Name |
Accumulation of $1,000 since 1957 |
Annual return |
| 1 |
Philip Morris |
$4,626,402 |
19.75% |
| 2 |
Abbott Labs |
$1,281,335 |
16.51% |
| 3 |
Bristol-Myers Squibb |
$1,209,445 |
16.36% |
| 4 |
Tootsie Roll Industries |
$1,090,955 |
16.11% |
| 5 |
Pfizer |
$1,054,823 |
16.03% |
| 6 |
Coca-Cola |
$1,051,646 |
16.02% |
| 7 |
Merck |
$1,003,410 |
15.90% |
| 8 |
PepsiCo |
$866,068 |
15.54% |
| 9 |
Colgate-Palmolive |
$761,163 |
15.22% |
| 10 |
Crane |
$736,796 |
15.14% |
| 11 |
H.J. Heinz |
$635,988 |
14.78% |
| 12 |
Wrigley |
$603,877 |
14.65% |
| 13 |
Fortune Brands |
$580,025 |
14.55% |
| 14 |
Kroger |
$546,793 |
14.41% |
| 15 |
Schering-Plough |
$537,050 |
14.36% |
| 16 |
Procter & Gamble |
$513,752 |
14.26% |
| 17 |
Hershey Foods |
$507,001 |
14.22% |
| 18 |
Wyeth |
$461,186 |
13.99% |
| 19 |
Royal Dutch Petroleum |
$398,837 |
13.64% |
| 20 |
General Mills |
$388,425 |
13.58% |
Source: The Future for Investors, Jeremy Siegel
|
